Cryo-Cell pushes further into Europe:
This article was originally published in Clinica
Cryo-Cell International, a US autologous umbilical cord cell bank, can expect major growth in Europe, the company's European chief operating officer Kees Kleinbloesem told the group's AGM last week. The centrepiece of recent successes has been a deal to open an autologous cord blood bank in Milan jointly with the Vatican-owned San Raphaelo Hospital in Milan. The Vatican has previously stated it support for autologous and/or clinical use of stem cells from umbilical cord blood, while being opposed to foetal or embryonic stem cells. Cryo-Cell is headquartered in Clearwater, Florida.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.